08158.HK
China Regenerative Medicine International Limited
HKSE · Healthcare · Biotechnology · HK
HKD 0.18
+0.00%Margins
Gross margin
56.4%
EBITDA margin
22.1%
EBIT margin
9.0%
Net margin
27.8%
FCF margin
14.5%
52.6%
Return on equity
20.8%
Return on assets
10.2%
Return on invested capital
0.75x
Asset turnover
HKD 15.6M
Cash from operations
HKD 0.01
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Jun 1, 2026